This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Citi Sticks to Its Buy Rating for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)

Tipranks - Tipranks - Wed Jun 17, 1:00AM CDT

Citi analyst Laura Sutcliffe maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh yesterday and set a price target of A$38.00.

Claim 55% Off TipRanks

Sutcliffe covers the Healthcare sector, focusing on stocks such as Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh, Resmed, and CSL. According to TipRanks, Sutcliffe has an average return of 0.7% and a 50.60% success rate on recommended stocks.

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has an analyst consensus of Strong Buy, with a price target consensus of A$41.27.

See the top stocks recommended by analysts >>

Based on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of A$1.42 billion and a net profit of A$395.1 million. In comparison, last year the company earned a revenue of A$1.29 billion and had a net profit of A$365.04 million

Read More on AU:RMD:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).